Comparison Overview

SomaDetect

VS

Roche

SomaDetect

241 Canada St, Fredericton, New Brunswick, E3A 4A1, CA
Last Update: 2026-04-03
View Profile
Between 700 and 749
http://www.somadetect.com

SomaDetect is an agricultural technology company that is connecting dairy farmers with the milk-quality indicators most relevant for the management of their production. Our optical technology allows for in-line measurements of critical dairy-quality indicators (fat content and somatic cells) from individual cows at every milking, enabling dairy farmers to identify problems early and produce the best possible milk.

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 17
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Roche

Grenzacherstrasse, Switzerland 🇨🇭 , 4070, CH
Last Update: 2026-04-01
Between 800 and 849
http://www.roche.com/

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 103,689
Subsidiaries: 51
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/somadetect.jpeg
SomaDetect
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/roche.jpeg
Roche
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
SomaDetect
100%
Compliance Rate
0/4 Standards Verified
Roche
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for SomaDetect in 2026.

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Roche in 2026.

Incident History — SomaDetect (X = Date, Y = Severity)

SomaDetect cyber incidents detection timeline including parent company and subsidiaries

Incident History — Roche (X = Date, Y = Severity)

Roche cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/somadetect.jpeg
SomaDetect
Incidents

No Incident

https://images.rankiteo.com/companyimages/roche.jpeg
Roche
Incidents

No Incident

FAQ

Roche company demonstrates a stronger AI Cybersecurity Score compared to SomaDetect company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Roche company has disclosed a higher number of cyber incidents compared to SomaDetect company.

In the current year, Roche company and SomaDetect company have not reported any cyber incidents.

Neither Roche company nor SomaDetect company has reported experiencing a ransomware attack publicly.

Neither Roche company nor SomaDetect company has reported experiencing a data breach publicly.

Neither Roche company nor SomaDetect company has reported experiencing targeted cyberattacks publicly.

Neither SomaDetect company nor Roche company has reported experiencing or disclosing vulnerabilities publicly.

Neither SomaDetect nor Roche holds any compliance certifications.

Neither company holds any compliance certifications.

Roche company has more subsidiaries worldwide compared to SomaDetect company.

Roche company employs more people globally than SomaDetect company, reflecting its scale as a Biotechnology Research.

Neither SomaDetect nor Roche holds SOC 2 Type 1 certification.

Neither SomaDetect nor Roche holds SOC 2 Type 2 certification.

Neither SomaDetect nor Roche holds ISO 27001 certification.

Neither SomaDetect nor Roche holds PCI DSS certification.

Neither SomaDetect nor Roche holds HIPAA certification.

Neither SomaDetect nor Roche holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hirschmann EagleSDV version 05.4.01 prior to 05.4.02 contains a denial-of-service vulnerability that causes the device to crash during session establishment when using TLS 1.0 or TLS 1.1. Attackers can trigger a crash by initiating TLS connections with these protocol versions to disrupt service availability.

Published
Date
2026-04-02
Updated
Date
2026-04-02
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

The stored API keys in temporary browser client is not marked as protected allowing for JavScript console or other errors to allow for extraction of the encryption credentials.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

XSS vulnerability in cveInterface.js allows for inject HTML to be passed to display, as cveInterface trusts input from CVE API services

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

Multiple reflected cross-site scripting (XSS) vulnerabilities in the login.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda and red_url parameters.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

A reflected cross-site scripting (XSS) vulnerability in the login_newpwd.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda parameter.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References